Correction: Wogonin Induces Cell Cycle Arrest and Erythroid Differentiation in Imatinib-Resistant K562 Cells and Primary CML Cells

Hao Yang,Hui,Qian Wang,Hui Li,Kai Zhao,Yuxin Zhou,Yu Zhu,Xiaotang Wang,You Qin,Qinglong Guo,Na Lu

DOI: https://doi.org/10.18632/oncotarget.27373

2020-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.2340.].

What problem does this paper attempt to address?

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Chao Hu,Mengxia Yu,Yanling Ren,Kongfei Li,Dominic M. Maggio,Chen Mei,Li Ye,Juying Wei,Jie Jin,Zhengping Zhuang,Hongyan Tong

DOI: https://doi.org/10.1038/s41598-017-14858-z

IF: 4.6

2017-01-01

Scientific Reports

Abstract:correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.
Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Xi Jiang,Chao Hu,Kyle Ferchen,Ji Nie,Xiaolong Cui,Chih-Hong Chen,Liting Cheng,Zhixiang Zuo,William Seibel,Chunjiang He,Yixuan Tang,Jennifer R. Skibbe,Mark Wunderlich,William C. Reinhold,Lei Dong,Chao Shen,Stephen Arnovitz,Bryan Ulrich,Jiuwei Lu,Hengyou Weng,Rui Su,Huilin Huang,Yungui Wang,Chenying Li,Xi Qin,James C. Mulloy,Yi Zheng,Jiajie Diao,Jie Jin,Chong Li,Paul P. Liu,Chuan He,Yuan Chen,Jianjun Chen

DOI: https://doi.org/10.1038/s41467-018-02947-0

IF: 16.6

2018-01-01

Nature Communications

Abstract:The original version of this Article contained an error in the spelling of the author James C. Mulloy, which was incorrectly given as James Mulloy. This has now been corrected in both the PDF and HTML versions of the Article.
Corrigendum: 5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells

Xuehua Zhang,Leilei Zhao,Jinlong Xiao,Yudi Wang,Yunmeng Li,Chaoqun Zhu,He Zhang,Yurui Zhang,Xiao Zhu,Yucui Dong

DOI: https://doi.org/10.3389/fonc.2024.1494738

IF: 4.7

2024-10-01

Frontiers in Oncology

Abstract:This article is a correction to: 5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells

oncology
Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Yu Zhang,Zu-Yun Li,Xin-Xi Hou,Xiao Wang,Yi-Huan Luo,Yan-Ping Ying,Gang Chen

DOI: https://doi.org/10.18632/oncotarget.28212

2022-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14972.].
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Corrigendum to “Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling”

Chenyang Zhao,Jinlan Gao,Sen Li,Qi Liu,Xiaoyu Hou,Shenghuan Liu,Xuesha Xing,Manni Sun,Shusen Wang,Yang Luo

DOI: https://doi.org/10.1155/2019/4104265

2019-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/6938482.].
Correction: Tumor Driven by Gain-of-function HER2 H878Y Mutant is Highly Sensitive to HER2 Inhibitor.

Zexi Hu,Yong Hu,Xicheng Liu,Rongwen Xi,Aiqun Zhang,Deruo Liu,Qiang Xie,Liang Chen

DOI: https://doi.org/10.18632/oncotarget.26252

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.5221.].
Correction To: Wogonoside Inhibits Invasion and Migration Through Suppressing TRAF2/4 Expression in Breast Cancer

Yuyuan Yao,Kai Zhao,Zhou Yu,Haochuan Ren,Li Zhao,Zhiyu Li,Qinglong Guo,Na Lu

DOI: https://doi.org/10.1186/s13046-019-1447-x

2017-01-01

Abstract:In the original publication of this article [1], there are mistakes in Fig. 3c and Fig. 3e.
[Corrigendum] Silencing of the long non‑coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial‑mesenchymal transition

Wenjie Xie,Xin Liu,Qiang Chen,Ming Ma,Xiaorong Yang,Binbin Gong,Ting Sun,Jie Chen

DOI: https://doi.org/10.3892/ol.2019.10369

2019-01-01

Oncology Letters

Abstract:[This corrects the article DOI: 10.3892/ol.2019.9967.].
Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum

Ping Ji,Yongxin Zhou,Yibao Yang,Junlu Wu,Hao Zhou,Wenqiang Quan,Junjun Sun,Yiwen Yao,Anquan Shang,Chenzheng Gu,Bingjie Zeng,Jenni Firrman,Weidong Xiao,Robert Bals,Zujun Sun,Dong Li

DOI: https://doi.org/10.7150/thno.82877

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.30726.].

medicine, research & experimental
Correction: Infiltrating Mast Cells Increase Prostate Cancer Chemotherapy and Radiotherapy Resistances Via Modulation of P38/p53/p21 and ATM Signals.

Hongjun Xie,Chong Li,Qiang Dang,Luke S Chang,Lei Li

DOI: https://doi.org/10.18632/oncotarget.27023

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.6372.].
Correction To: IGFBP7 Inhibits Cell Proliferation by Suppressing AKT Activity and Cell Cycle Progression in Thyroid Carcinoma.

Le Zhang,Rong Lian,Jingjing Zhao,Xianming Feng,Runyi Ye,Lingxiao Pan,Jueheng Wu,Mengfeng Li,Yongbo Huang,Junchao Cai

DOI: https://doi.org/10.1186/s13578-019-0319-6

2019-01-01

Cell & Bioscience

Abstract:[This corrects the article DOI: 10.1186/s13578-019-0310-2.].
Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Wei Wang,Bo Hu,Jiang-Jiang Qin,Jianwen Cheng,Xin Li,Mehrdad Rajaei,Jia Fan,Xin-Rong Yang,Ruiwen Zhang

DOI: https://doi.org/10.1016/j.gendis.2019.12.006

IF: 7.376

2019-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].
Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Huan Shi,Xin-Yu LI,Yao Chen,Xing Zhang,Yong Wu,Zi-Xuan Wang,Pan-Hong Chen,Hui-Qi Dai,Ji Feng,Sayantan Chatterjee,Zhong-Jie Li,Xiao-Wei Huang,Hong-Qiao Wei,Jigang Wang,Guo-Dong Lu,Jing Zhou

DOI: https://doi.org/10.3389/fphar.2020.640750

IF: 5.6

2021-02-08

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.534171.].

pharmacology & pharmacy
Corrigendum: Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy

Yihui Zhou,Xiaomeng Gao,Yuan Meng,Bo Yang,Qiaojun He,Ji Cao

DOI: https://doi.org/10.3389/fphar.2021.785732

IF: 5.6

2021-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.748852.].
Correction: Cepharanthine Hydrochloride Reverses the Mdr1 (P-Glycoprotein)-mediated Esophageal Squamous Cell Carcinoma Cell Cisplatin Resistance Through JNK and P53 Signals

Pengjun Zhou,Rong Zhang,Ying Wang,Dandan Xu,Li Zhang,Jinhong Qin,Guifeng Su,Yue Feng,Hongce Chen,Siyuan You,Wen Rui,Huizhong Liu,Suhong Chen,Hongyuan Chen,Yifei Wang

DOI: https://doi.org/10.18632/oncotarget.27638

2021-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.22676.].
Author Correction: Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated β-catenin loss in hepatocellular carcinoma

Man Zhu,Zhengyan Gong,Qing Wu,Qi Su,Tianfeng Yang,Runze Yu,Rui Xu,Yanmin Zhang

DOI: https://doi.org/10.1038/s41419-024-07034-5

2024-09-03

Cell Death and Disease

Abstract:Cell Death & Disease, Published online: 02 September 2024; doi:10.1038/s41419-024-07034-5 Author Correction: Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated β-catenin loss in hepatocellular carcinoma

cell biology
Erratum: KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p: Erratum.

Mimi Zhou,Jinqiu Chen,Hui Zhang,Hailing Liu,Huan Yao,Xiaman Wang,Wanggang Zhang,Yingren Zhao,Nan Yang

DOI: https://doi.org/10.7150/ijbs.77067

2022-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.45999.].

Correction: Wogonin Induces Cell Cycle Arrest and Erythroid Differentiation in Imatinib-Resistant K562 Cells and Primary CML Cells

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Corrigendum: 5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells

Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum to “Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling”

Correction: Tumor Driven by Gain-of-function HER2 H878Y Mutant is Highly Sensitive to HER2 Inhibitor.

Correction To: Wogonoside Inhibits Invasion and Migration Through Suppressing TRAF2/4 Expression in Breast Cancer

[Corrigendum] Silencing of the long non‑coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial‑mesenchymal transition

Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum

Correction: Infiltrating Mast Cells Increase Prostate Cancer Chemotherapy and Radiotherapy Resistances Via Modulation of P38/p53/p21 and ATM Signals.

Correction To: IGFBP7 Inhibits Cell Proliferation by Suppressing AKT Activity and Cell Cycle Progression in Thyroid Carcinoma.

Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Corrigendum: Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy

Correction: Cepharanthine Hydrochloride Reverses the Mdr1 (P-Glycoprotein)-mediated Esophageal Squamous Cell Carcinoma Cell Cisplatin Resistance Through JNK and P53 Signals

Author Correction: Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated β-catenin loss in hepatocellular carcinoma

Erratum: KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p: Erratum.